SOURCE: BIOLASE Technology, Inc.

December 21, 2006 07:30 ET

BIOLASE to Present at the Needham Growth Stock Conference in New York City

IRVINE, CA -- (MARKET WIRE) -- December 21, 2006 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, announced today that President and CEO Jeffrey W. Jones and CFO Richard L. Harrison are scheduled to make an investor presentation at the Ninth Annual Needham Growth Stock Conference on Wednesday, January 10 at 4:30 p.m. Eastern Time. The conference is being held January 9-12 at the New York Palace Hotel.

The presentation will be accessible by live web cast on the investor relations section of the BIOLASE web site at A replay of the web cast will be available on the BIOLASE web site for 60 days.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (, the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. The Company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the Waterlase® system, is one of the best selling dental laser systems. The Waterlase system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The Company also offers the LaserSmile™ system, which uses a laser to perform soft tissue and cosmetic procedures, including teeth whitening. The Company is also developing a laser for use in the field of ophthalmology.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:

    Jeffrey W. Jones
    President & CEO

    Richard L. Harrison
    Executive Vice President and CFO

    BIOLASE Technology, Inc.

    Jill Bertotti
    Allen & Caron